title: Scope for prevention of diabetes--'focus intrauterine milieu interieur'.
abstract: The prevalence of diabetes is increasing globally and India is no exception. The lifestyle modification and drug intervention are likely to delay or postpone the development of overt diabetes in persons diagnosed to have impaired glucose tolerance. This is a post primary prevention strategy. The primary prevention is more important as this effort is likely to reverse or halt the epidemic of disease. Women with Gestational Diabetes Mellitus (GDM) are an ideal group for the primary prevention of diabetes as they are at increased risk of future diabetes, predominantly type 2 diabetes, as are their children. Pima Indians have the highest prevalence of diabetes. This is attributed to the children exposed in utero to maternal diabetes. Hence as a policy to identify GDM and its consequences on the infant, a 75 gm Oral Glucose Tolerance Test has been recommended to all Pima Indian women during the 3rd trimester of pregnancy. Ethnically Asian Indian women also have high prevalence of diabetes and the relative risk of developing Gestational Diabetes Mellitus in them is 11.3 times compared to White women. This necessitates universal screening for gestational diabetes during pregnancy in India. Probably the undiagnosed gestational diabetes that has been occurring in the past has resulted in the increased prevalence of diabetes in India. The timely action taken now in screening all pregnant women for glucose intolerance, achieving euglycemia in them and ensuring adequate nutrition may prevent in all possibility, India becoming the diabetes capital of the world.
authors.affiliation: Diabetes Unit, Apollo Hospitals, Chennai.
authors.forename: V
authors.initials: V
authors.lastname: Seshiah
authors.forename: V
authors.initials: V
authors.lastname: Balaji
authors.forename: Madhuri S
authors.initials: MS
authors.lastname: Balaji
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control; D016640:Diabetes, Gestational / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007194:India; D008403:Mass Screening; D011247:Pregnancy; D011322:Primary Prevention